Updated algorithms for using B-type natriuretic peptide (BNP) levels in the diagnosis and management of congestive heart failure.

The growing popularity of BNP testing is a testimony to its usefulness for diagnosing and managing patients with congestive heart failure. The algorithms in this article are based on the most-up-to-date evidence-based medicine we have intermingled with clinical judgement of someone who has used BNP testing since its inception.

[1]  S. Mudaliar,et al.  Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. , 2003, Diabetes care.

[2]  S. Goldhaber,et al.  Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism , 2003, Circulation.

[3]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[4]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[5]  L. Morrison,et al.  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. , 2002, Annals of emergency medicine.

[6]  L. Morrison,et al.  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea ☆ , 2002 .

[7]  M. Sabatine,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[8]  P. Krishnaswamy,et al.  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. , 2001, Journal of cardiac failure.

[9]  L. Lenert,et al.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. , 2001, Journal of the American College of Cardiology.

[10]  L. Lenert,et al.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.

[11]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[12]  L. Stevenson.  Tailored therapy to hemodynamic goals for advanced heart failure , 1999, European journal of heart failure.

[13]  W. Weintraub.  Clinical cardiovascular databases: ready for prime time? , 1998, American heart journal.

[14]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[15]  K. Nakao,et al.  Brain natriuretic peptide predicts mortality in the elderly. , 1997, Heart.

[16]  H. Itoh,et al.  Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. , 1995, Circulation.

[17]  K. Freedland,et al.  Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failure. , 1988, American journal of public health.

[18]  Y Wang,et al.  Predictors of readmission among elderly survivors of admission with heart failure. , 2000, American heart journal.

[19]  S. Kuribayashi,et al.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. , 1998, Journal of the American College of Cardiology.